Skip to Main Content

Paper Details

Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors.
Clin Cancer Res
5
2022
MET, Tumor, Tumors, amplified segment, genomic, malignancies, neoplastic, neoplastic cell, solid tumors, tumors
Author NameAffiliation
Ronglai ShenMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Alexander DrilonMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2